SABS, SAB Biotherapeutics, Inc

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for SABS

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, and more.


News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask SABS by Subscribing to iPick.ai Premium!



Stock Chart



Competitors:


Latest YouTube Video:



CEO:Mr. Samuel J. Reich

Headquarter: 777 W 41st St., Miami Beach, FL, United States, 33140

Industry: Biotechnology,   Investment Track: -,   Employees: 86

Business Summary

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.